Extensive literature describes GDF15 as a biomarker for a number of diverse pathologies or conditions such as diabetes, cardiovascular disease [72], obesity [73, 74], cancer [75, 76], mitochondrial disease [77], and aging [78]. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.